![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 1, 187-193, January 4, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Acetylation of histone core
particles plays an important role in modulating chromatin structure and
gene expression. The acetylation status of the histone tails is
determined by two opposing enzymatic activities, histone
acetyltransferases and histone deacetylases (HDACs). Here we
describe the isolation and characterization of HDAC10, a novel class II
histone deacetylase. Molecular cloning and Northern blot analyses
reveal that the HDAC10 transcript is widely expressed and
subjected to alternative splicing. HDAC10 is both nuclear and
cytoplasmic, a feature reminiscent of HDACs 4, 5, and 7. Distinct from
other family members, HDAC10 harbors an amino-terminal catalytic domain
and a carboxyl pseudo-repeat that shares significant homology with its
catalytic domain. Mutational analysis reveals that transcriptional
repression by HDAC10 requires its intrinsic histone deacetylase
activity. Taken together, HDAC10 represents a distinct HDAC that may
play a role in transcription regulation.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF407272 (HDAC10
Isolation and Characterization of Mammalian HDAC10, a Novel
Histone Deacetylase*
§,
,
, and
Department of Biochemistry, School of
Medicine, Case Western Reserve University (CWRU), the Research
Institute of University Hospitals of Cleveland (UHC), and the
Comprehensive Cancer Center of CWRU and UHC, Cleveland, Ohio 44106 and
the ¶ Howard Hughes Medical Institute, Gene Expression Laboratory,
The Salk Institute for Biological Studies, La Jolla, California
92037
*
This work was supported by a start-up fund (to H. Y. K.)
and National Institutes of Health Grant HD27183 (to R. M. E.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
) and AF407273 (HDAC10
).
Investigator of the Howard Hughes Medical Institute at the
Salk Institute for Biological Studies, and March of Dimes Chair in
Molecular and Developmental Biology. To whom correspondence may be
addressed: The Howard Hughes Medical Institute, Gene Expression Laboratory, The Salk Institute for Biological Studies, 10010 Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-453-4100, Ext. 1585; Fax:
858-455-1349; E-mail: evans@salk.edu.
This article has been cited by other articles:
![]() |
C. Gao, C.-C. Ho, E. Reineke, M. Lam, X. Cheng, K. J. Stanya, Y. Liu, S. Chakraborty, H.-M. Shih, and H.-Y. Kao Histone Deacetylase 7 Promotes PML Sumoylation and Is Essential for PML Nuclear Body Formation Mol. Cell. Biol., September 15, 2008; 28(18): 5658 - 5667. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gao, X. Cheng, M. Lam, Y. Liu, Q. Liu, K.-S. Chang, and H.-Y. Kao Signal-dependent Regulation of Transcription by Histone Deacetylase 7 Involves Recruitment to Promyelocytic Leukemia Protein Nuclear Bodies Mol. Biol. Cell, July 1, 2008; 19(7): 3020 - 3027. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fournel, C. Bonfils, Y. Hou, P. T. Yan, M.-C. Trachy-Bourget, A. Kalita, J. Liu, A.-H. Lu, N. Z. Zhou, M.-F. Robert, et al. MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo Mol. Cancer Ther., April 1, 2008; 7(4): 759 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fukuda, N. Sano, S. Muto, and M. Horikoshi Simple histone acetylation plays a complex role in the regulation of gene expression. Brief Funct Genomic Proteomic, September 1, 2006; 5(3): 190 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, P. K. Sengupta, E. Seto, and B. D. Smith Regulatory Factor for X-box Family Proteins Differentially Interact with Histone Deacetylases to Repress Collagen {alpha}2(I) Gene (COL1A2) Expression J. Biol. Chem., April 7, 2006; 281(14): 9260 - 9270. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Yoo, J.-J. Chung, S. S. Choe, K. H. Kim, and J. B. Kim Down-regulation of Histone Deacetylases Stimulates Adipocyte Differentiation J. Biol. Chem., March 10, 2006; 281(10): 6608 - 6615. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Mukhopadhyay, E. Weisberg, D. Gilchrist, R. Bueno, D. J. Sugarbaker, and M. T. Jaklitsch Effectiveness of Trichostatin A as a Potential Candidate for Anticancer Therapy in Non-Small-Cell Lung Cancer. Ann. Thorac. Surg., March 1, 2006; 81(3): 1034 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Yang and S. Gregoire Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication Mol. Cell. Biol., April 15, 2005; 25(8): 2873 - 2884. [Full Text] [PDF] |
||||
![]() |
D. Waltregny, L. de Leval, W. Glenisson, S. Ly Tran, B. J. North, A. Bellahcene, U. Weidle, E. Verdin, and V. Castronovo Expression of Histone Deacetylase 8, a Class I Histone Deacetylase, Is Restricted to Cells Showing Smooth Muscle Differentiation in Normal Human Tissues Am. J. Pathol., August 1, 2004; 165(2): 553 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hu, E. Dul, C.-M. Sung, Z. Chen, R. Kirkpatrick, G.-F. Zhang, K. Johanson, R. Liu, A. Lago, G. Hofmann, et al. Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 720 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Davie Inhibition of Histone Deacetylase Activity by Butyrate J. Nutr., July 1, 2003; 133(7): 2485S - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ju and M. T. Muller Histone Deacetylase Inhibitors Activate p21WAF1 Expression via ATM Cancer Res., June 1, 2003; 63(11): 2891 - 2897. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Berger, C. Bieniossek, C. Schaffitzel, M. Hassler, E. Santelli, and T. J. Richmond Direct Interaction of Ca2+/Calmodulin Inhibits Histone Deacetylase 5 Repressor Core Binding to Myocyte Enhancer Factor 2 J. Biol. Chem., May 9, 2003; 278(20): 17625 - 17635. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Petrie, F. Guidez, L. Howell, L. Healy, S. Waxman, M. Greaves, and A. Zelent The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms J. Biol. Chem., April 25, 2003; 278(18): 16059 - 16072. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. De Schepper, H. Bruwiere, T. Verhulst, U. Steller, L. Andries, W. Wouters, M. Janicot, J. Arts, and J. Van heusden Inhibition of Histone Deacetylases by Chlamydocin Induces Apoptosis and Proteasome-Mediated Degradation of Survivin J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 881 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Glaser, M. J. Staver, J. F. Waring, J. Stender, R. G. Ulrich, and S. K. Davidsen Gene Expression Profiling of Multiple Histone Deacetylase (HDAC) Inhibitors: Defining a Common Gene Set Produced by HDAC Inhibition in T24 and MDA Carcinoma Cell Lines Mol. Cancer Ther., February 1, 2003; 2(2): 151 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ding, L. L. Gillespie, and G. D. Paterno Human MI-ER1 Alpha and Beta Function as Transcriptional Repressors by Recruitment of Histone Deacetylase 1 to Their Conserved ELM2 Domain Mol. Cell. Biol., January 1, 2003; 23(1): 250 - 258. [Abstract] [Full Text] |
||||
![]() |
J. J. Westendorf, S. K. Zaidi, J. E. Cascino, R. Kahler, A. J. van Wijnen, J. B. Lian, M. Yoshida, G. S. Stein, and X. Li Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter Mol. Cell. Biol., November 15, 2002; 22(22): 7982 - 7992. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Butler, X. Zhou, W.-S. Xu, H. I. Scher, R. A. Rifkind, P. A. Marks, and V. M. Richon The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin PNAS, September 3, 2002; 99(18): 11700 - 11705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fournel, M.-C. Trachy-Bourget, P. T. Yan, A. Kalita, C. Bonfils, C. Beaulieu, S. Frechette, S. Leit, E. Abou-Khalil, S.-H. Woo, et al. Sulfonamide Anilides, a Novel Class of Histone Deacetylase Inhibitors, Are Antiproliferative against Human Tumors Cancer Res., August 1, 2002; 62(15): 4325 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. David, M. A. Neptune, and R. A. DePinho SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities J. Biol. Chem., June 21, 2002; 277(26): 23658 - 23663. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lemercier, M.-P. Brocard, F. Puvion-Dutilleul, H.-Y. Kao, O. Albagli, and S. Khochbin Class II Histone Deacetylases Are Directly Recruited by BCL6 Transcriptional Repressor J. Biol. Chem., June 7, 2002; 277(24): 22045 - 22052. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Hartman, X. Hu, K. X. Tyler, C. K. Dalal, and M. A. Lazar Mechanisms Regulating Adipocyte Expression of Resistin J. Biol. Chem., May 24, 2002; 277(22): 19754 - 19761. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Tong, J. Liu, N. R. Bertos, and X.-J. Yang Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain Nucleic Acids Res., March 1, 2002; 30(5): 1114 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Richon and J. P. O'Brien Histone Deacetylase Inhibitors: A New Class of Potential Therapeutic Agents for Cancer Treatment : Commentary re: V. Sandor et al., Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms. Clin. Cancer Res., 8: 718-728, 2002. Clin. Cancer Res., March 1, 2002; 8(3): 662 - 664. [Full Text] [PDF] |
||||
![]() |
D. D. Fischer, R. Cai, U. Bhatia, F. A. M. Asselbergs, C. Song, R. Terry, N. Trogani, R. Widmer, P. Atadja, and D. Cohen Isolation and Characterization of a Novel Class II Histone Deacetylase, HDAC10 J. Biol. Chem., February 15, 2002; 277(8): 6656 - 6666. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |